10/14/2020 ASN Kidney Week 2020 Reimagined: Disclosures Page 1 Last Name First Name Nothing Employer Consultancy Ownership Interest Research Funding Honoraria Patents or Inventions Scientific Advisor or Membership Speakers Bureau Other Interests or Relationships to Disclose Abdel-Kader Khaled Vanderbilt University Medical Center BMC Nephrology; CJASN NKF Education committee; NIDDK Health IT work group Abudayyeh Ala University of Texas MD Anderson Cancer Center Adler Sharon Retrophin; Bristol Myers Squibb; Bayer; Retrophin; Bayer; ChemoCentryx; Omeros; Zyversa Bayer; Zyversa; Retrophin; AstraZeneca; Morphosys Retrophin; Bayer Pharmaceuticals; Zyversa; KDIGO; KRN; NephCure Kidney International AstraZeneca; ChemoCentryx; Omeros; Zyversa; Therapeutics; Calliditas; Morphosys AstraZeneca; Morphosys Foundation; Karger Publishers Morphosys; Karger Afkarian Maryam University of California, Davis Afrouzian Marjan University of Texas Medical Branch Alexion Pharmaceuticals; Banff Foundation Afshinnia Farsad Agarwal Anupam University of Alabama at Birmingham Dynamed - review content related to AKI for Goldilocks Therapeutics Genzyme/Sanofi Fabry Fellowship Award Univ Southern California, Vanderbilt, Emory, Akebia Editorial Board of AJP Renal, Kidney Int and My wife, Lisa Curtis, will be President-elect Dynamed and review updated materials prepared by Lab Investigation; invited to serve on for Women in Nephrology (2018-2019). Dynamed editorial team for AKI topics. Akebia - Advisory board of Goldilocks Therapeutics, Expert Panel to review new therapeutics based on company investigating delivery of drugs in HIF pathway for AKI. Reata - Consultant. kidney using nanotechnology for acute and chronic kidney disease; served on External evaluation panel for Kidney Precision Medicine Program (KPMP); invited to serve on Advisory Board of Angion and Alpha Young Agarwal Krishna BIDMC Founder, MEDSICON; Founder, I-MediSTAR Agarwal Rajiv VA Medical Center, Indiana University, IU Abbvie, Akebia, Amgen, AstraZeneca, Bayer, Abbvie, Akebia, Amgen, AstraZeneca, Bayer, KDIGO, Hypertension, NDT, AJN, JASH, Heath Physicians Birdrock Bio, Boehringer Ingelheim, Celgene, Daiichi Birdrock Bio, Boehringer Ingelheim, Celgene, Daiichi Seminars in Dialysis, Akebia, AstraZeneca, Sankyo, Eli Lilly, GlaxoSmithKline, Ironwood Sankyo, Eli Lilly, GlaxoSmithKline, Ironwood Bayer, Boehringer Ingelheim, Eli Lilly, Pharmaceuticals, Johnson & Johnson, Merck, Pharmaceuticals, Johnson & Johnson, Merck, Ironwood Pharmaceuticals, Johnson & Novartis, Opko, Otsuka, Reata, Relypsa, Sandoz, Novartis, Opko, Otsuka, Reata, Relypsa, Sandoz, Johnson, Reata, Relypsa, and Sanofi Sanofi Takeda ZS Pharma Sanofi Takeda ZS Pharma Agraz Irene Vall d'Hebron Univesitary Hospital Akizawa Tadao Showa University School of Medicine Kyowa Kirin, Bayer, Astellas, GlaxoSmithKline, JT, Kyowa Kirin, Bayer, Kissei, Chugai, Fuso, Astellas, Bayer, Kyowa Kirin, Ono, Chugai, Nipro, Ono, Torii, Sanwa Chemical, Fuso,Kissei, Torii Torii, Fuso, Kissei, Astellas Otsuka Al sahlawi Muthana Alachkar Nada Johns Hopkins University UpToDate Alberici Federico University of Brescia Alexander Mariam Allegretti Andrew MGH Mallinckrodt Allon Michael University of Alabama at Birmingham CorMedix Alpers Charles University of Washington AstraZeneca; Retrophin; Novo Nordisk Abbvie; Boehringer-Ingelheim; Sana Editorial Boards: CJASN; Laboratory Investigation; American Journal of Pathology; Journal of Nephrology; Kidney 360; American Journal of Kidney Diseases Al-Rabadi Laith University of Utah Hospital Amann Kerstin University Hospital Erlangen Alexion; AstraZeneca; Bayer Andeen Nicole Oregon Health & Science University Anders Hans Klinikum der Universitat Munchen Previpharma; Secarna, NOXXON, AstraZeneca, Novartis, GSK, Bayer, Janssen, Boehringer Anderson Amanda Tulane University National Institutes of Health Anker Stefan Charité Medical School Vifor Pharma, Boehringer Ingelheim, Bayer, Servier, Vifor Pharma, Abbott Vascular Novartis, Cardiac Dimensions Impulse Dynamics Arnott Clare The George Institute for Global Health Aronson Peter Yale University School of Medicine Various universities and academic societies for Royalties for anti-transporter Kidney Section Editor, Annual Review of seminars and lectures monoclonal antibodies used in Physiology; Editorial Board, American research Journal of Physiology; Editorial Board, Function Arthur John University of Arkansas for Medical Sciences; Department of Veterans Affairs Askenazi David University of Alabama at Birmingham Baxter, CHF solutions; Medtronic; Bioporto, AKI Baxter Renal Products; CHF solutions foundation Atkinson Meredith Johns Hopkins University School of Medicine National Kidney Foundation of Maryland - (self); AstraZeneca (spouse) Advisory Board member Atta Mohamed Johns Hopkins School of Medicine Institutional funding with GSK, Alnylam, Sentient, Amgen BMS Attanasio Massimo University of Iowa Avasare Rupali Oregon Health & Science University Avila Ana Hospital Dr Peset Alexion, GSK Alexion; GSK Alexion Awdishu Linda UCSD Skaggs School of Pharmacy and Medscape; Postgraduate Healthcare Education / National Kidney Foundation - Travel and American Board of Internal Medicine Pharmaceutical Sciences Power-Pak C.E. Registration; ASN - Travel; American Board of Nephrology Board Internal Medicine - Travel and Registration Azzi Jamil Brigham and Women's Hospital, Harvard American Diabetes Association; American Heart Intellectual Properties and Royalties CareDx: scientific advisory Medical School Association; Qatar Research Fund from Accrue Health; Intellectual Properties in ExosomeDx Babitt Jodie Massachussetts General Hospital, Harvard Incyte Ferrumax Pharmaceuticals Massachusetts General Hospital, Editorial Board: American Journal of Medical School Ferrumax Pharmaceuticals Physiology, Renal Physiology; Board of Directors: International BioIron Society; Co- Chair: KDIGO Anemia Guideline Update 10/14/2020 ASN Kidney Week 2020 Reimagined: Disclosures Page 2 Last Name First Name Nothing Employer Consultancy Ownership Interest Research Funding Honoraria Patents or Inventions Scientific Advisor or Membership Speakers Bureau Other Interests or Relationships to Disclose Hallym University Dongtan Sacred Heart Baek Seon Ha Hospital Bagshaw Sean University of Alberta Baxter; CNA Diagnostics; Spectral Medical CNA Diagnostics Baxter Baxter Baxter Healthcare (Advisory); CNA Baxter Healthcare Diagnostics (Advisory); Spectral Medical (Steering Committee); Cytopherix Inc. (Data Safety Monitoring Board); Critical Care (Editorial Board); BioPorto (Adjudication Committee) Bahena-López Jessica Bailey Clifford Aston University Abbott; Lexicon AZ; BI; MSD; Napp; Novo; Sanofi Diabetes and Vascular Disease Research; Diabetes Obesity metabolism; Primary Care Diabetes; Therapeutic Advances in Endocrinology and Metabolism Bailis Will University of Pennsylvania Bakris George University of Chicago Medicine Relypsa, Janssen, Bayer, Vascular Dynamics, KBP, Bayer, Novo Nordisk-Funding for steering committee Merck, Novo Nordisk, AstraZeneca, Relypsa Merck, Relypsa, KBP, American J Merck, Novo Nordisk, AstraZeneca, Ionis, Alynalam activities and goes to University of Chicago Nephrology, Editor, Diabetes Care, Assoc Ed, Hypertension Research-Assoc Ed; American Heart Assoc; UpToDate- Nephrology Balogun Rasheed University of Virginia American Society for Apheresis Board Member (professional organization); Review (Associate) Editor, Journal for Clinical Apheresis; National Medical Association, Chair of Internal Medicine Steering Committee and Chair of Nephrology subspecialty (professional organization) Bansal Amar University of Pittsburgh Medical Center Gilead UpToDate Bansal Nisha University of Washington CJASN; AJKD Barbour Sean University of British Columbia Visterra, Inception Sciences, Achillion Roche Roche, Alexion Bargman Joanne University Health Network Baxter Healthcare, Davita Healthcare Partners, Editorial Boards: JASN, Peritoneal Dialysis DaVita Healthcare Partners, Baxter Amgen International, CJASN Canada, Baxter Global Barisoni Laura Elpidera; Protalix; Amicus; Sangamo, Vertex Sangamo, Vertex, Protalix Renal Pathology Society, BOD; Nephcure Nephcure scientific advisory Board; Nature Review Nephrology Barone Sharon University of New Mexico; Veterans Administration, Research Services, Albuquerque, NM Barratt Jonathan University of Leicester AduroBiotech; EMD Serono; Kancera; Omeros; Novartis; GlaxoSmithKline; Calliditas, Visterra, AstraZeneca Editorial Board of Kidney International, Calliditas; Novartis; Retrophin, Visterra, Alnylam AduroBioTech CJASN & Clinical Science Barreto Erin Mayo Clinic Fast Biomedical FAST Biomedical Barua Moumita Toronto General Hospital, University Health Otsuka; Regulus; Sanofi Network, Mt Sinai Hospital Basu Rajit Children's Healthcare of Atlanta Baxter Healthcare Solutions; BioPorto Diagnostics, Bioporto Diagnostics; Baxter Biomerieux, Potrero, BD Batal Ibrahim Columbia University American Society of Transplantation Baum Michelle Boston Children Hospital (Children's Hospital Retrophin; Dicerna Clinical trial participant with Dicerna Retrophin; Dicerna Retrophin: Scientific advisory board; Dicerna: PI of studies in primary hyperoxaluria with Pediatric Associates) Advisory board; Oxalosis/Hyperoxaluria Dicerna Foundation: Scientific advisory board; Dent Disease Foundation: Scientific advisory board; ASN/KHI: KHI member of: Identification of Appropriate Endpoints for Clinical Trials in Hyperoxaluria Bavanandan Sunita Baxter Healthcare National Kidney Foundation of Malaysia